NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 01:57PM ET
24.36
Dollar change
+0.19
Percentage change
0.79
%
Index- P/E24.48 EPS (ttm)0.99 Insider Own0.07% Shs Outstand586.83M Perf Week3.00%
Market Cap14.30B Forward P/E10.64 EPS next Y2.29 Insider Trans0.00% Shs Float586.39M Perf Month0.41%
Income583.85M PEG1.58 EPS next Q0.43 Inst Own5.80% Short Float0.14% Perf Quarter-1.10%
Sales20.91B P/S0.68 EPS this Y24.80% Inst Trans0.52% Short Ratio2.27 Perf Half Y16.61%
Book/sh25.72 P/B0.95 EPS next Y12.40% ROA1.62% Short Interest0.79M Perf Year13.41%
Cash/sh2.35 P/C10.38 EPS next 5Y15.46% ROE3.87% 52W Range17.93 - 25.96 Perf YTD7.60%
Dividend Est.0.84 (3.45%) P/FCF7.83 EPS past 5Y-14.87% ROI2.32% 52W High-6.16% Beta0.85
Dividend TTM0.64 (2.64%) Quick Ratio0.99 Sales past 5Y1.38% Gross Margin24.60% 52W Low35.86% ATR (14)0.68
Dividend Ex-DateMay 17, 2024 Current Ratio1.38 EPS Y/Y TTM8.25% Oper. Margin8.46% RSI (14)52.23 Volatility1.75% 2.41%
Employees113840 Debt/Eq0.75 Sales Y/Y TTM-0.57% Profit Margin2.79% Recom2.68 Target Price26.23
Option/ShortYes / Yes LT Debt/Eq0.67 EPS Q/Q-64.64% Payout- Rel Volume0.62 Prev Close24.17
Sales Surprise7.53% EPS Surprise12.90% Sales Q/Q1.12% EarningsFeb 25 BMO Avg Volume349.26K Price24.36
SMA200.76% SMA501.55% SMA20010.84% Trades Volume151,809 Change0.79%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Upgrade BofA Securities Underperform → Neutral
Nov-06-24Initiated Berenberg Buy $25.60
Jan-08-24Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-24-23Upgrade HSBC Securities Reduce → Hold
Nov-17-23Upgrade Societe Generale Hold → Buy
Aug-14-23Downgrade UBS Buy → Neutral
Aug-01-23Resumed Citigroup Neutral
Jul-12-23Initiated Goldman Buy
Mar-07-23Initiated Bernstein Mkt Perform
Jan-03-23Downgrade Jefferies Buy → Underperform $14 → $11.70
Today 12:50PM
12:48PM
Apr-24-25 01:02PM
11:36AM
Apr-23-25 12:39PM
09:40AM Loading…
09:40AM
Apr-21-25 09:57AM
Apr-17-25 09:40AM
08:50AM
Apr-16-25 09:07AM
06:30AM
Apr-15-25 09:45AM
Apr-14-25 09:40AM
Apr-11-25 09:50AM
Apr-10-25 01:19PM
09:03AM Loading…
09:03AM
Apr-09-25 08:57AM
Apr-07-25 09:40AM
Apr-04-25 12:37PM
11:02AM
09:40AM
08:27AM
Apr-03-25 11:30AM
Apr-02-25 03:34PM
08:35AM
Apr-01-25 10:41AM
10:02AM
09:42AM
09:40AM
Mar-31-25 08:47AM
11:30AM Loading…
Mar-28-25 11:30AM
10:25AM
Mar-27-25 05:00AM
05:00AM
Mar-26-25 11:59AM
11:44AM
07:47AM
Mar-25-25 10:39AM
Mar-24-25 11:50AM
10:15AM
10:15AM
07:41AM
Mar-20-25 09:40AM
09:38AM
05:00AM
Mar-19-25 10:15AM
Mar-13-25 08:00AM
Mar-04-25 02:50AM
Feb-25-25 10:15AM
07:00AM
Feb-24-25 08:00AM
Jan-07-25 07:57AM
Dec-23-24 09:00AM
Dec-20-24 11:23AM
Nov-19-24 09:00AM
Nov-06-24 06:33AM
Nov-05-24 10:19AM
07:00AM
02:05AM
Oct-21-24 11:04AM
Sep-10-24 07:51PM
Sep-04-24 08:00AM
Aug-07-24 08:57PM
Jul-30-24 02:43PM
07:00AM
Jul-08-24 07:59AM
Jun-19-24 09:40AM
Jun-12-24 08:00AM
Jun-11-24 02:23PM
Jun-07-24 11:02AM
May-30-24 07:07AM
May-23-24 12:33PM
May-21-24 10:00AM
May-16-24 09:55AM
08:50AM
May-08-24 11:23AM
May-07-24 01:53PM
01:01PM
07:00AM
01:36AM
Apr-10-24 09:36AM
Mar-25-24 11:10AM
10:59AM
10:46AM
Mar-22-24 08:00AM
Mar-19-24 08:00AM
Mar-15-24 10:14AM
Mar-11-24 09:42AM
Mar-06-24 05:02PM
Mar-05-24 03:34PM
10:10AM
10:09AM
Feb-21-24 09:36AM
02:49AM
Feb-20-24 01:10PM
07:30AM
01:44AM
Feb-17-24 03:19AM
Feb-08-24 08:54AM
Feb-05-24 08:57AM
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.